| Market Cap | ₹1,993Cr |
| ROE | 6.31% |
| P/E Ratio(TTM) | 20.09 |
| EPS(TTM) | 1.81 |
| P/B Ratio | 1.67 |
| Dividend Yield | 0.55% |
| Industry P/E | 31.89 |
| Book Value | 21.83 |
| Debt to Equity | 0.13 |
| Face Value | 2 |
| Managing Director | Mr. Sushil Suri |
| NSE Symbol | MOREPENLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.81 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.88 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Natco Pharma | NA (0.00%) | 9.74 |